Consumer Edge: Efficacy Claims Are Beauty’s New Share-Gainer

A new Consumer Edge transaction-data read says brands that can prove product efficacy are taking share as overall beauty spending cools — exactly the kind of signal buy-side teams pay…

Consumer Edge has built its franchise on card-linked transaction panels that let funds see spend shifts before retailers report them, and a beauty-category efficacy angle is a natural extension — if a brand’s repeat-purchase and share-of-wallet numbers move ahead of ad spend or influencer buzz, that’s the kind of divergence discretionary and quant beauty pods actually trade on.

The trick, as always with this genre of vendor research, is separating a genuine leading indicator from a marketing note dressed up as insight. “Efficacy-led” is a soft descriptor until you see the underlying cohort methodology — panel size, merchant coverage, how they’re isolating efficacy claims from price or promo effects in a slowing category.

In a shrinking pie, share data is worth more than growth data — which is exactly when alt-data vendors start pitching hardest.

Worth watching whether Consumer Edge turns this into a recurring beauty-sector index that sourcing teams can trial and backtest, rather than a one-off note — that’s usually what separates a dataset with staying power from a press-cycle deliverable.

Consumer Edge Data Reveals Efficacy-Led Brands Winning Share in a Slowing Beauty Market

AOL.com

Read the full story at AOL.com →

The Data Commenter, in your inbox

Data markets, alt data, and the AI training-data economy. No spam, unsubscribe anytime.

Leave a Reply

Your email address will not be published. Required fields are marked *